Brown Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Brown Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,177	Closed	-$203K	–	127
2023 Q2	$203K	Hold	3,177	–	–	﹤0.01%	126
2023 Q1	$220K	Hold	3,177	–	–	﹤0.01%	124
2022 Q4	$229K	Hold	3,177	–	–	﹤0.01%	124
2022 Q3	$226K	Hold	3,177	–	–	﹤0.01%	121
2022 Q2	$245K	Hold	3,177	–	–	﹤0.01%	120
2022 Q1	$232K	Buy	+3,177	New	+$213K	﹤0.01%	124
2021 Q4	–	Sell	-4,394	Closed	-$260K	–	130
2021 Q3	$260K	Hold	4,394	–	–	﹤0.01%	121
2021 Q2	$294K	Hold	4,394	–	–	﹤0.01%	118
2021 Q1	$277K	Hold	4,394	–	–	﹤0.01%	122
2020 Q4	$273K	Hold	4,394	–	–	﹤0.01%	119
2020 Q3	$265K	Hold	4,394	–	–	﹤0.01%	111
2020 Q2	$258K	Hold	4,394	–	–	﹤0.01%	114
2020 Q1	$245K	Sell	4,394 -6,280	-59%	-$384K	﹤0.01%	111
2019 Q4	$685K	Buy	+10,674	New	+$611K	0.01%	97

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Brown Capital Management's BMY Position: Q3 2023 in Review

Brown Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,177 shares — an estimated $203K sold.

Brown Capital Management first reported a position in BMY in Q4 2019 and held it in 14 quarters. The position peaked at $685K in Q4 2019. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Brown Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Brown Capital Management sold 3,177 Bristol-Myers Squibb shares in Q3 2023, an estimated $203K.
Brown Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 14 quarters.
Brown Capital Management's Bristol-Myers Squibb position peaked at $685K in Q4 2019.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Brown Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.